ADMA Biologics's total assets for Q1 2025 were $510.57M, an increase of 4.48% from the previous quarter. ADMA total liabilities were $137.15M for the fiscal quarter, a -1.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.